Commercial price is similar to Pfizer’s plans for after government contracting ends
Even at higher per-dose pricing, sales of Moderna’s Covid-19 vaccine are expected to decline.Moderna Considers Price
Moderna Inc. said it is considering pricing its Covid-19 vaccine in a range of $110 to $130 per dose in the U.S. when it shifts from government contracting to commercial distribution of the shots.
The range is similar to the one Pfizer Inc. said in October it was considering for the Covid-19 vaccine it developed with BioNTech SE.
“I would think this type of pricing is consistent with the value” provided by the vaccine, Moderna Chief Executive Officer Stephane Bancel said in an interview Monday on the sidelines of the J.P. Morgan Healthcare Conference in San Francisco.Moderna Considers Price
The expected price for commercial insurers would be significantly higher than the per-dose cost in Moderna’s supply contracts with the federal government. Moderna’s updated booster shots cost about $26 per dose in a federal supply contract signed in July 2022. The original vaccine cost about $15 to $16 per dose in earlier supply contracts.
See More: Wilmington man to take ‘dream’ anniversary trip after winning $1M on scratch ticket
